ZVRA
Zevra Therapeutics, Inc.Company with tickers: ZVRA
CIK
1434647
CUSIP
488445206
Shares Outstanding
59,115,084
13F Activity (30d)
124 filings
120 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K/A | 2024-02-05 | 2023-11-20 | |
| 8-K | 2024-02-28 | 2024-02-22 | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-03-05 | — | |
| 8-K | 2024-03-27 | 2024-03-26 | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-04-10 | 2024-04-04 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-06-03 | — | |
| 8-K | 2024-07-09 | — | |
| 8-K | 2024-07-12 | — | |
| 8-K | 2024-08-05 | 2024-08-02 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-08-09 | 2024-08-08 | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-09-20 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-22 | 2024-11-21 | |
| 8-K | 2024-12-06 | 2024-12-02 | |
| 8-K | 2025-02-27 | 2025-02-26 | |
| 8-K | 2025-03-11 | — | |
| 10-K | 2025-03-12 | 2024-12-31 | |
| 8-K | 2025-04-07 | 2025-04-01 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-05-29 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-11-20 | — | |
| 8-K | 2025-12-02 | 2025-11-26 | |
| 8-K | 2025-12-17 | 2025-12-11 | |
| 10-K | 2026-03-09 | 2025-12-31 | |
| 8-K | 2026-03-09 | 2026-03-04 | |
| 8-K | 2026-03-16 | 2026-03-12 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — |
Showing 101–143 of 143 filings